Welcome to our dedicated page for MRCR news (Ticker: MRCR), a resource for investors and traders seeking the latest updates and insights on MRCR stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MRCR's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MRCR's position in the market.
Blackford Capital announced it will acquire Moro Corporation (OTC:MRCR) in an all-cash merger announced December 29, 2025. The deal values Moro at approximately $34.2 million or $5.59 per share, with about $3.3 million (≈$0.55 per share) placed in escrow and holdbacks under the merger agreement.
The transaction was approved by both boards and by Moro stockholders holding the requisite majority and is subject to customary closing conditions. The companies expect the deal to close promptly. Upon closing, Moro's OTC quotation will be suspended.
